Variant · Snv
RNASEH2B NM_024570.4(RNASEH2B):c.322-54T>G
CI-VAR-00201891Explore in graph →NM_024570.4:c.322-54T>GClinVar 1314877 rs41292768
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1314877 | Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Ovarian serous cystadenocarcinoma; Uterine corpus endometrial carcinoma; Sarcoma; Cholangiocarcinoma; Gastric cancer; Malignant tumor of esophagus; Lung cancer; Cervical cancer; Thymoma; Acute myeloid leukemia | germline | 3 | Apr 29, 2021 | clinvar |